ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR Convergence 2025

Abstract Number: 0719

A Combined Transcriptomics and Proteomics Approach to Identify Immune Signatures in ANCA-Associated Glomerulonephritis

Ivana Stojkic1, Arnon Arazi2, Huijuan Song3, Pearlly Yan3, Estela Puchulu-Campanella3, Hubao Wang3, Lynn Fussner3, Brad Rovin4, Stacy Ardoin1 and Salem Almaani3, 1Nationwide Children's Hospital, Columbus, OH, 2The Feinstein Institutes for Medical Research, Manhasset, 3OSU, Columbus, OH, 4The Ohio State University, Columbus, OH

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR Convergence 2025

Keywords: gender, Vasculitis

Session Information

Date: Sunday, October 26, 2025

Title: (0711–0730) Vasculitis – ANCA-Associated Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: ANCA-associated vasculitis frequently involves the kidneys causing glomerulonephritis (AAGN). Despite advances in treatment, many patients develop end-stage kidney disease. An improved understanding of the immune drivers of AAGN has the potential to improve treatment outcomes. To achieve that goal, we utilized a combined transcriptomics/compartmental proteomics approach to identify the major immune pathways driving AAGN.

Methods: Formalin-fixed paraffin embedded kidney biopsies of 23 patients with AAGN and 5 healthy controls (pre-implantation kidney donor biopsy) were used. For transcriptomics, RNA was extracted and bulk RNAseq was performed on all 23 AAGN biopsies and controls. Differential expression analysis was performed using the DESeq framework. For proteomics, laser capture microdissection was utilized to collect the glomerular and tubulointerstitial compartments separately using 10 AAGN biopsies and all controls. Peptides were extracted and submitted for mass-spectrometric analysis. After normalization, differential expression analysis was done using T-tests. The Benjamini-Hochberg method was used for multiple hypothesis testing correction in all experiments. Differentially abundant mRNA and peptide spectral counts were used to identify enriched immune pathways using Ingenuity pathway analysis.

Results: Patient and disease characteristics of the full (transcriptomic) and proteomics cohort are described in table 1. The top enriched pathways in each of the 3 experiments (whole tissue transcriptomics, glomerular proteomics, tubulointerstitial proteomics) are depicted in Figure 1a-c. Comparison analysis using data from the 3 experiments demonstrated many shared enriched and upregulated pathways including complement, neutrophil degranulation, and FC gamma receptor signaling. PD-1/PDL1 and IL-10 signaling were downregulated across the 3 tissues studied. Upstream analysis demonstrated upregulation of TNF, INF-gamma, INF-alpha, and IL-6.

Conclusion: Analysis of biopsies from patients with AAGN demonstrated largely similar upregulated/downregulated immune pathways and upstream regulators when comparing transcriptomic and compartmental proteomics approaches. These may help inform patient stratification and therapy development.

Supporting image 1

Supporting image 2Top 20 upregulated pathways of immunologic relevance in a) transcriptomic data b) glomerular proteomic data and c) tubulointerstitial proteomic data

Supporting image 3Heatmap of identified canonical pathways and upstream regulators across transcriptomic and proteomic datasets


Disclosures: I. Stojkic: None; A. Arazi: None; H. Song: None; P. Yan: None; E. Puchulu-Campanella: None; H. Wang: None; L. Fussner: None; B. Rovin: Alexion, 2, Artiva, 2, 11, AstraZeneca, 2, Aurinia, 2, 5, Biogen, 2, 5, Bristol Myers Squibb, 2, Cabelleta, 2, Century, 2, F. Hoffman-La Roche Ltd/Genentech, Inc., 2, GlaxoSmithKlein(GSK), 2, Novartis, 2; S. Ardoin: None; S. Almaani: None.

To cite this abstract in AMA style:

Stojkic I, Arazi A, Song H, Yan P, Puchulu-Campanella E, Wang H, Fussner L, Rovin B, Ardoin S, Almaani S. A Combined Transcriptomics and Proteomics Approach to Identify Immune Signatures in ANCA-Associated Glomerulonephritis [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/a-combined-transcriptomics-and-proteomics-approach-to-identify-immune-signatures-in-anca-associated-glomerulonephritis/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-combined-transcriptomics-and-proteomics-approach-to-identify-immune-signatures-in-anca-associated-glomerulonephritis/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology